Finding the right funding solution for a company at the right time is a key element of our 21st century merchant banking approach. 

A company that endeavours to raise capital to deliver on its strategy may find the best solution is to raise public equity, either through an initial public offering or with follow-on equity for a company that already has a public listing. We raise equity for growth and mid-cap companies, both public and private, at different stages of development and for a range of purposes. 

We have more experience than most: we first raised equity for a client more than 140 years ago.

Our corporate advisory and broking team supports capital raisings across our sectors by working closely with research analysts who are experts in their fields and with our sales and equity execution teams who have a deep understanding of what equity investors look for. 

a selection of client transactions

JULY 2018

Allergy Therapeutics plc

Secondary Offering

Financial Adviser, Nominated Adviser and Broker

£11 million

MAR 2018

Summit Therapeutics plc

Secondary Offering

Joint Broker and Joint Bookrunner

£15 million

FEB 2018

Faron Pharmaceuticals Ov

Secondary Offering

Financial Adviser, Broker and Sole Bookrunner

£15 million

NOV 2017

Keystone Law Group plc

Initial Public Offering raising £15M

Nominated Advisor and Broker

£50 million

OCT 2017

Hutchinson China MediTech Ltd

Secondary Offering


$301 million

JUN 2017

Eland Oil & Gas plc

Secondary Offering

Lead Bookrunner

$20 million

“I would have no hesitation in recommending Panmure Gordon to any other business contemplating an IPO.”

Quiz Founder & CEO, Tarak Ramzan


Dominic Morley

Head of Corporate Advisory

Erik Anderson

Head of Corporate Broking